Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical modelsTing-Yu Chang(Taipei Medical University), Sung‐Bau Lee(Taipei Medical University)Journal of Clinical InvestigationOctober 22, 202410.1172/jci165448Cited by 8SaveCiteExport RISWatch citationsRelated PapersTousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors|Science Advances|2018|65Quinoline-5,8-Dione CDC25 Inhibitors: Potent Anti-Cancer Agents in Leukemia and Patient-Derived Colorectal Organoids|Research Square|2025|0